small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (835)
  • Capabilities (76)
  • Experience (53)
  • Insights & News (2,659)
  • Other Results (55)

Professionals 835 results

Glenn S. Shubb
Glenn S. Shubb
Managing Director
  • Los Angeles
Email
+1 213-615-1772
vCard

Managing Director

  • Los Angeles
James B. Gambulos
James B. Gambulos
Associate
  • Dallas
Email
+1 214-296-9806
vCard

Associate

  • Dallas
Changyoung Kim
Changyoung Kim
Attorney
  • New York
Email
+1 212-294-3349
vCard

Attorney

  • New York
View All Professionals

Capabilities 76 results

Practice Area

International Arbitration

Winston has decades of experience representing clients in international arbitrations around the world. Representing clients in both commercial and investor-state international arbitrations, we are well known by the leading players in the global arbitration arena. Our integrated team of attorneys enforces awards worldwide, knows every angle of international disputes, and has a robust understanding of our client’s industries....Read more

Industry

Sports

Winston has one of the world’s premier sports law practices. Our work has included some of the most famous legal matters in sports history—including Alston v. NCAA, the case that culminated in a 9–0 Supreme Court victory for the college players against the NCAA; the US$2.15B Los Angeles Dodgers acquisition; McNeil v. the NFL, the landmark antitrust jury trial that led to the establishment of free agency in the NFL; the multi-billion-dollar construction and permanent financings for SoFi Stadium; and Morgan v. USSF, the case that led to a historic equal pay settlement for the players on the Women’s National Team. Our work is transforming this global, multibillion-dollar industry....Read more

Practice Area

Antitrust/Competition

Experience 53 results

Experience

|

September 8, 2025

Winston Wins Ninth Circuit Reversal and Class Certification in Swimmers’ Antitrust Case, Securing a Global-Impact Settlement with World Aquatics

Winston represents a class of professional swimmers alleging World Aquatics (WA) violated antitrust laws by blocking their participation in the competing  International Swimming League. After WA won summary judgment, Winston successfully appealed, arguing the court applied improper antitrust standards and wrongly denied certification of a damages class. In September 2024, the Ninth Circuit reversed both rulings, reviving all claims and issuing a landmark ruling on the possible application of the per se rule or quick look review to sports-associations rules. Am Law awarded Winston “Litigator of the Week” Runner-Up recognition for the win. In November 2024, the Ninth Circuit denied rehearing. In April 2025, the district court certified a damages class....Read more

Experience

|

July 11, 2025

Winston Represented South Reach Networks in Sale to Blue Owl

Winston represented Intermetro Fiber, LLC (d/b/a South Reach Networks (SRN)), a Florida-based fiber optic infrastructure provider, in its sale to a fund managed by affiliates Blue Owl Capital  (Blue Owl). This acquisition will allow Blue Owl to provide incremental scale and deepen Blue Owl's existing fiber capabilities, adding major new builds across the network, and scale the business to meet the growing need for additional fiber optic network capabilities across SRN's dark and lit fiber optic infrastructure network which spans 370 miles from Jacksonville to Miami....Read more

Experience

|

May 9, 2025

An Am Law LOTW Shout Out-Worthy Gold Medal Victory In $Jenner

Winston, led by partners Jeffrey Steinfeld, John Schreiber, and George Mastoris, secured full dismissal of a high-profile securities class action involving hundred of millions of dollars in $Jenner memecoin trades. Plaintiffs alleged securities fraud under federal and California laws. The team was recognized in Am Law’s Litigator of the Week column for the win....Read more
View All Experience

Insights & News 2,659 results

Sponsorship

|

November 20, 2025

Winston & Strawn Sponsors 2025 Smart Business Dealmakers South Florida M&A Conference

Winston & Strawn is proud to sponsor the upcoming Smart Business Dealmakers South Florida M&A Conference. The conference brings together hundreds of local dealmakers, including middle-market CEOs, top investors and lenders, and leading M&A advisers....Read more

Capital Markets & Securities Law Watch

|

November 14, 2025

|

6 Min Read

Back in Business: What the SEC’s Post-Shutdown Guidance Means for Issuers and Underwriters

On November 13, 2025, following the end of the federal government shutdown, the Securities and Exchange Commission (SEC) issued guidance that offers much‑needed clarity to issuers, underwriters, and advisors navigating filings made during and immediately after the shutdown. With more than 900 registration statements filed during the shutdown, questions quickly mounted regarding automatic effectiveness, the treatment of missing information under Rule 430A, acceleration mechanics, and the status of filings already in the review pipeline. The staff (the Staff) of the SEC’s Division of Corporation Finance (the Division) addressed these topics directly through a series of Questions and Answers. This alert explains the guidance, describes the practical implications for capital markets and M&A participants, and recommends near‑term steps to adapt filing and transaction timelines.

Client Alert

|

November 12, 2025

|

3 Min Read

Take Notice: California Expands Healthcare Transaction Notification Regime

Just five days after tightening restrictions on the corporate practice of medicine for hedge funds and private equity groups, on October 11, 2025, California Governor Gavin Newsom signed Assembly Bill 1415 (AB 1415) into law, expanding the types of entities and transactions that must be reported to the California Office of Health Care Affordability (OHCA) under the state’s healthcare transaction review law....Read more
View All Insights & News

Other Results 55 results

Site Content

Associate Salary Disclosures

Law Glossary

What Exclusivity Periods Are Associated with Biosimilars?

An applicant may not submit an aBLA until four years after the reference product is licensed by the FDA. (See BPCIA § 351(k).) Further, any biosimilar licenses “may not be made effective” until 12 years after the reference product was licensed. (See BPCIA § 351(l).)...Read more

Site Content

Japan Practice

Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising